Novoray Corporation (SHA:688300)
China · Delayed Price · Currency is CNY 84.32
+1.26 (1.52%)
Nov 5, 2026, 3:00 PM CST
Novoray Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,338 | 1,114 | 959.16 | 710.99 | 660.91 | 623.82 |
Other Revenue | 1.37 | 1.37 | 1.2 | 0.69 | 1.04 | 0.89 |
| 1,339 | 1,116 | 960.36 | 711.68 | 661.95 | 624.71 | |
Revenue Growth | 22.78% | 16.16% | 34.94% | 7.51% | 5.96% | 54.55% |
Cost of Revenue | 827.35 | 664.46 | 573.9 | 432.97 | 402.9 | 359.6 |
Gross Profit | 511.54 | 451.04 | 386.46 | 278.71 | 259.05 | 265.11 |
Selling, General & Admin | 79.96 | 71.83 | 66.66 | 59.18 | 52.57 | 46.67 |
Research & Development | 69.85 | 64.17 | 60.4 | 47.4 | 38.5 | 35.06 |
Other Operating Expenses | -5.1 | 5.44 | 3.83 | -7.84 | 6.86 | 5.88 |
Operating Expenses | 145.48 | 141.09 | 131.57 | 98.95 | 96.5 | 87.36 |
Operating Income | 366.05 | 309.95 | 254.89 | 179.76 | 162.55 | 177.75 |
Interest Expense | -9.21 | -1.45 | -3.29 | -2.03 | -2 | -0.28 |
Interest & Investment Income | 15.36 | 19.29 | 21.46 | 14.1 | 6.68 | 13.14 |
Currency Exchange Gain (Loss) | -9.19 | -9.19 | 2.96 | 1.16 | 8.44 | -1.53 |
Other Non Operating Income (Expenses) | -11.01 | -0.38 | -0.22 | -0.27 | -0.27 | -0.21 |
EBT Excluding Unusual Items | 352.01 | 318.21 | 275.79 | 192.71 | 175.4 | 188.87 |
Gain (Loss) on Sale of Investments | 13.69 | 2.68 | -1 | 2.68 | 2.16 | 0.8 |
Gain (Loss) on Sale of Assets | -1.04 | -1.26 | -0.38 | -0.02 | -0.83 | 0.08 |
Asset Writedown | 0.33 | - | - | - | - | - |
Other Unusual Items | 14.6 | 14.6 | 11.77 | 1.99 | 16.42 | 7.65 |
Pretax Income | 379.58 | 334.23 | 286.19 | 197.36 | 193.15 | 197.4 |
Income Tax Expense | 46.8 | 41.59 | 34.81 | 23.37 | 4.91 | 24.53 |
Net Income | 332.78 | 292.64 | 251.37 | 173.99 | 188.24 | 172.87 |
Net Income to Common | 332.78 | 292.64 | 251.37 | 173.99 | 188.24 | 172.87 |
Net Income Growth | 16.14% | 16.42% | 44.47% | -7.57% | 8.89% | 55.85% |
Shares Outstanding (Basic) | 314 | 314 | 314 | 313 | 315 | 313 |
Shares Outstanding (Diluted) | 317 | 314 | 314 | 313 | 315 | 313 |
Shares Change | 21.30% | 0.06% | 0.45% | -0.69% | 0.58% | -0.25% |
EPS (Basic) | 1.06 | 0.93 | 0.80 | 0.56 | 0.60 | 0.55 |
EPS (Diluted) | 1.05 | 0.93 | 0.80 | 0.56 | 0.60 | 0.55 |
EPS Growth | -4.25% | 16.35% | 43.83% | -6.93% | 8.26% | 56.24% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 69.6 | 157.16 | 165.13 | 193.93 | 85.86 | -54.55 |
Free Cash Flow Per Share | 0.22 | 0.50 | 0.53 | 0.62 | 0.27 | -0.17 |
Dividend Per Share | 0.385 | 0.385 | 0.296 | 0.296 | 0.181 | 0.167 |
Dividend Growth | 29.98% | 29.98% | 0% | 63.75% | 8.53% | 21.62% |
Gross Margin | 38.21% | 40.43% | 40.24% | 39.16% | 39.13% | 42.44% |
Operating Margin | 27.34% | 27.79% | 26.54% | 25.26% | 24.56% | 28.45% |
Profit Margin | 24.86% | 26.23% | 26.17% | 24.45% | 28.44% | 27.67% |
Free Cash Flow Margin | 5.20% | 14.09% | 17.19% | 27.25% | 12.97% | -8.73% |
EBITDA | 427.92 | 368.18 | 308.28 | 229.41 | 198.9 | 200.67 |
EBITDA Margin | 31.96% | 33.01% | 32.10% | 32.23% | 30.05% | 32.12% |
D&A For EBITDA | 61.86 | 58.23 | 53.4 | 49.65 | 36.36 | 22.92 |
EBIT | 366.05 | 309.95 | 254.89 | 179.76 | 162.55 | 177.75 |
EBIT Margin | 27.34% | 27.79% | 26.54% | 25.26% | 24.56% | 28.45% |
Effective Tax Rate | 12.33% | 12.44% | 12.16% | 11.84% | 2.54% | 12.43% |
Revenue as Reported | 1,339 | 1,116 | 960.36 | 711.68 | 661.95 | 624.71 |